Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia

US Patent 8962594 · Granted Feb 24, 2015

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →